Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Deracoxib: From COX-2 Inhibition to Translation
2026-09-17
Deracoxib is more than a selective COX-2 inhibitor for routine pain studies. Its value in translational research lies in connecting prostaglandin control with nitric oxide signaling, tumor-cell survival, model-specific pharmacology, and carefully designed combination experiments. This article outlines how to build more informative inflammation assays and canine cancer biology workflows around that mechanistic framework.
-
Cy3 NHS ester (non-sulfonated) Workflow Guide
2026-09-17
Cy3 NHS ester (non-sulfonated) provides a non-sulfonated NHS-activated fluorophore for covalent labeling of accessible amino groups in proteins, peptides, and amino-modified oligonucleotides. It is appropriate when DMSO, DMF, or compatible ethanol-containing workflows are acceptable, but it is a poor choice for delicate biomolecules that require strictly aqueous labeling.
-
Phytol Workflows for RXR Signaling and Assays
2026-09-16
Build more reproducible Phytol experiments by controlling solubility, isomer composition, dose range, and pathway-specific readouts. This guide connects RXR-focused cell assays with PPARα and GABAergic follow-up studies while using polymer self-assembly research to sharpen experimental design without overstating cross-domain evidence.
-
Biomimetic Chromatography for Lung Permeability
2026-09-16
This study evaluates IAM-LC and OT-CEC-MS as biomimetic, mass-spectrometry-compatible models for pulmonary drug permeability. Its findings show that IAM-LC can correlate well with apparent permeability for larger compounds, while OT-CEC-MS provides complementary information on phospholipid composition and drug–membrane interactions.
-
ECL Chemiluminescent Substrate Detection Kit for TNBC
2026-09-15
Apply hypersensitive ECL to validate low-abundance signaling proteins in TNBC models, including Lin28B and PBK. This workflow combines extended signal duration, reduced background, and practical optimization guidance for Western blot experiments where conventional detection may miss biologically important changes.
-
ATM Inhibition and Fenofibrate in HGSOC
2026-09-15
The reference study identifies a metabolic vulnerability created by ATM inhibition in high-grade serous ovarian cancer cells. Its combination of bioinformatic analysis, drug-dependency data, and cell-based validation suggests that pairing an ATM kinase inhibitor with fenofibrate can promote senescence, particularly in tumors that are not readily addressed by homologous recombination-directed therapies.
-
Diclofenac in Inflammation and Organoid Research
2026-09-14
Diclofenac is a non-selective COX inhibitor used to reduce prostaglandin synthesis in inflammation and pain signaling research. Its defined chemical identity, high supplier-reported purity, and compatibility with human pluripotent stem cell-derived intestinal organoid workflows support controlled cyclooxygenase inhibition assay design.
-
MK-1775: Wee1 Kinase Inhibitor Workflow
2026-09-14
MK-1775 helps researchers connect Wee1 inhibition with G2 checkpoint abrogation, mitotic entry, and DNA-damage sensitivity in cancer models. Its strongest use-case is not simply measuring growth inhibition, but separating cytostasis from cell killing across p53-defined models and treatment schedules.
-
Batimastat (BB-94): Mapping Proteolytic Signaling
2026-09-13
Explore how Batimastat (BB-94) can separate extracellular MMP activity from intracellular BDNF processing in cancer and neuromuscular assays. This mechanistic guide emphasizes compartment-resolved experimental design, assay controls, and responsible interpretation of broad-spectrum inhibition.
-
Droplet Digital CRISPR-Cas13a for m6A Detection
2026-09-12
The reference study introduces a droplet digital CRISPR-Cas13a workflow for amplification-free detection of N6-methyladenosine (m6A) in RNA. By combining m6A-specific antibody enrichment with Cas13a recognition and droplet partitioning, the method supports femtomolar-level measurement and estimation of methylation-site proportions without PCR-related loss of epigenetic information.
-
SN-38 Beyond TOP1: A Translational Research Playbook
2026-09-11
7-Ethyl-10-hydroxycamptothecin, also known as SN-38, offers translational researchers a way to connect topoisomerase I inhibition with FUBP1–FUSE disruption, cell-cycle control, and apoptosis in advanced colon cancer research.
-
HotStart Universal 2X FAST Green qPCR Master Mix Guide
2026-09-11
Build fast, inhibitor-tolerant gene expression assays around Green I fluorescence and a universal ROX reference signal. This workflow translates albiflorin-related renal cell carcinoma findings into practical qPCR choices for target validation, pathway studies, and reproducible biomarker screening.
-
DFO for Latent Fingerprint Detection
2026-09-10
DFO (9H-1,8-Diazafluoren-9-one) converts amino acid residues in latent prints into a fluorescence-based signal that is particularly useful on paper and other porous evidence. This practical guide covers reagent handling, substrate-aware workflows, imaging controls, and troubleshooting while placing the method alongside recent orthogonal assay-design lessons from zebrafish toxicology.
-
S Tag Peptide: Practical Fusion-Tag Workflow
2026-09-10
S Tag Peptide is a short, highly soluble fusion tag for improving recombinant protein solubility and supporting antibody-based detection or purification. This guide covers construct design, aqueous handling, QC, and failure analysis; it should not be used as a standalone ribonuclease or in workflows requiring ethanol solubility or long-term solution storage.
-
Red Blood Cell Lysis Buffer for Bone Research
2026-09-09
Red Blood Cell Lysis Buffer can improve blood sample preparation when bone and immune biology studies require clean leukocyte or molecular readouts. This article connects selective erythrocyte removal with the RUNX2–AMPK findings of a trelagliptin osteoblast study while defining practical assay boundaries.